Ramos, JR, Perrín, RS, Martín, MAG, Clemente, YC, Díez, MA, Pinto, AD, Díaz, AS, Almela, AFD, Serrano, PS, Grande, ASL, Blanco, CC. Adverse drug events associated with emergency departments visits. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/025.2025. PMID:. IF:6.300(Q1/1D).

Villegas, E, Arruñada, M, Casado, MA, González, S, Moreno-Martínez, ME, Peñuelas, MA, Torres, AM, Sierra, Y, Seguí, MA. National expert consensus on home-administered oncologic therapies in Spain. Frontiers in Oncology. 2024; 14DOI:10.3389/fonc.2024.1335344. PMID:38434688. IF:3.300(Q2/4D).

Torres, T, Chiricozzi, A, Puig, L, Lé, AM, Marzano, AV, Dapavo, P, Dauden, E, Carrascosa, JM, Lazaridou, E, Duarte, G, Carvalho, AVE, Romiti, R, Rompoti, N, Teixeira, L, Abreu, M, Ippoliti, E, Maronese, CA, Llamas-Velasco, M, Vilarrasa, E, del Alcázar, E, Daponte, AI, Papoutsaki, M, Carugno, A, Bellinato, F, Gisondi, P. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2024; 25(2)DOI:10.1007/s40257-024-00845-4. PMID:38265746. IF:8.800(Q1/1D).

Torres, T, Sood, S, Yilmaz, O, Vender, RB, Prajapati, V, Puig, L, Megna, M, Marzano, AV, Gisondi, P, Carrascosa, JM, Dauden, E, Llamas-Velasco, M, Balato, A, Leal, BG, Prignano, F, Bellinato, F, Silvi, G, Di Brizzi, E, Potestio, L, Sechi, A, Carrera, CG, López-Ferrer, A, Del-Alcazar, E, Mufti, A, Maul, LV, Piaserico, S, Maul, JT, Yeung, J. Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicentre retrospective study. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2025; 50(12)DOI:10.1093/ced/llaf342. PMID:40726424. IF:2.800(Q2/4D).

Zeng, GH, Zhong, W, Mazzon, G, Zhu, W, Lahme, S, Khadgi, S, Desai, J, Agrawal, M, Schulsinger, D, Gupta, M, Montanari, E, Martinez, JML, Almousawi, S, Malonzo, VEF, Sriprasad, S, Arumuham, V, Ferretti, S, Kamal, W, Xu, KW, Cheng, F, Gao, XF, Cheng, JW, Somani, B, Duvdevani, M, Git, KA, Seitz, C, Bernardo, N, Ibrahim, TAA, Aquino, A, Yasui, T, Fiori, C, Knoll, T, Papatsoris, A, Gadzhiev, N, Zhanbyrbekuly, U, Angerri, O, Ramos, HL, Saltirov, I, Moussa, M, Giusti, G, Vicentini, F, Suarez, EB, Pearle, M, Preminger, GM, Wu, QH, Durutovic, O, Ghani, K, Maroccolo, M, Brehmer, M, Osther, PJ, Zawadzki, M, Tursunkulov, A, Kytaibekovich, MN, Abuvohidov, AA, Lara, CAR, Noori, Z, Zanetti, SP, Shrestha, S, de la Rosette, J, Denstedt, J, Ye, ZQ, Sarica, K, Choong, S. International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy. Military Medical Research. 2024; 11(1)DOI:10.1186/s40779-024-00562-3. PMID:39465407. IF:22.900(Q1/1D).

Soria, F, Rosazza, M, Livoti, S, Dutto, D, Colucci, F, Sylvester, RJ, Shariat, SF, Babjuk, M, Palou, J, Gontero, P. Repeat Transurethral Resection (TUR) plus Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. European Urology Focus. 2024; 10(4)DOI:10.1016/j.euf.2023.10.019. PMID:37923633. IF:5.600(Q1/1D).